Eye Health News and Research

Latest Eye Health News and Research

Children with JIA face increase risk of developing cancer

Children with juvenile idiopathic arthritis have a two to threefold increased risk of developing cancer compared to similarly-aged children without JIA, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta. The same study also reported no cases of cancer in children with JIA who were exposed to anti-TNF therapy.

9 Nov 2010

DHA protects brain tissue and promotes recovery in acute ischemic stroke

Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours.

9 Nov 2010

TransTech Pharma, High Point receive $1.96 million grants under QTDP program

TransTech Pharma, Inc. and High Point Pharmaceuticals, LLC. today announced that they have been awarded cash grants totaling $1.96 million under the U.S. Government's Qualifying Therapeutic Discovery Project program.

8 Nov 2010

Angioblast Systems receives $1.2 million in grants under QTDP program

Regenerative medicine company, Mesoblast Limited, today announced that its United States associate company, Angioblast Systems, has been awarded $1.2 million in grants under the United States Government's Qualifying Therapeutic Discovery Project (QTDP) program.

8 Nov 2010

Researchers identify gene linked to melanoma metastasis

Researchers at Washington University School of Medicine in St. Louis have identified a gene linked to the spread of eye melanoma.

8 Nov 2010

'Phantom' images brain keeps for visual comparisons stored in brain's neural network

Brain research over the past 30 years has shown that if a part of the brain controlling movement or sensation or language is lost because of a stroke or injury, other parts of the brain can take over the lost function - often as well as the region that was lost.

4 Nov 2010

FIP Annual Meeting to improve global health through advances in pharmaceutical sciences

Global health crises like the recent cholera outbreak in Haiti emphasize the need for new ways to prevent deadly diseases from becoming widespread in developing countries. International experts and scientists will present research ranging from developing a freeze-dried cholera vaccine to new methods of delivering medicines to underserved populations at the 2010 International Pharmaceutical Federation (FIP) Pharmaceutical Sciences World Congress (PSWC) in association with the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in New Orleans, La., Nov. 13-18.

4 Nov 2010

pSivida awarded $489,000 grant under IRS Qualifying Therapeutic Discovery Project

pSivida Corp., a leader in the development of sustained release drug delivery products for the treatment of back-of-the-eye disease including the product candidate Iluvien™ for the treatment of Diabetic Macular Edema, today announced that it has been awarded two grants totaling $489,000 under the IRS Qualifying Therapeutic Discovery Project (QTDP). The grants were awarded to pSivida to help fund further research on new generations of the company's drug delivery technologies targeting ophthalmic diseases.

4 Nov 2010

Republicans look to use majority for health overhaul repeal, plan vote

Now in control of the House of Representatives, Republicans are planning to flex their muscles quickly to try to repeal the Democratic health law but even some GOP leaders acknowledge it is likely they can get rid of the law right away.

4 Nov 2010

Acton submits Manufacturing Supplement to FDA for AEROSPAN Inhalation Aerosol

Acton Pharmaceuticals, Inc. today announced that it has submitted to the U.S. Food and Drug Administration (FDA), a Manufacturing Supplement to the previously approved AEROSPAN Inhalation Aerosol NDA.

4 Nov 2010

Eye implant restores some vision in retinitis pigmentosa

According to a new scientific breakthrough, a device - a tiny, three-by-three millimetre microchip, has allowed patients with inherited blindness to detect objects with their eyes, unlike a rival approach that uses an external camera. The procedure details are outlined in the journal Proceedings of the Royal Society B.

3 Nov 2010

QLT third quarter sales decreases 12.9% to $20.5 million

QLT Inc. today reported financial results for the third quarter ended September 30, 2010. Unless specified otherwise, all amounts are in U.S. dollars and in accordance with U.S. GAAP.

3 Nov 2010

Northumbria University to host workshop on space exercise countermeasures and post mission rehabilitation

Space travel experts from around the world will gather at Northumbria University to discuss ways to tackle health issues faced by astronauts during lengthy extra terrestrial missions.

3 Nov 2010

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

AstraZeneca announced today that results from TITAN, a 12-week study of SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol in African American patients with moderate to severe persistent asthma, showed significant improvement in lung function for patients taking SYMBICORT compared with those using budesonide alone.

3 Nov 2010

Retina Implant's microchip restores useful vision in patients blind due to retinitis pigmentosa

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the publication of a peer-reviewed study in Proceedings of the Royal Society B discussing the technical and clinical results obtained during their first human clinical trial.

3 Nov 2010

OMJPI enters agreement with Watson to distribute generic version of CONCERTA tablets

Ortho-McNeil-Janssen Pharmaceuticals, Inc. today announced it has entered into a supply and distribution agreement with Watson Laboratories, Inc. to distribute an authorized generic version of CONCERTA (methylphenidate HCl extended-release tablets).

3 Nov 2010

STAAR Surgical third quarter total net sales increases 6% to $13.2 million

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the third quarter ended October 1, 2010. Revenue for the period grew 6% to $13.2 million reflecting core product (IOLs and ICLs) revenue growth of 10% and a 44% decrease in defocused product revenue as compared to the third quarter of 2009.

3 Nov 2010

ISTA third quarter net revenue increases 31% to $42.0 million

ISTA Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2010. Third quarter 2010 net revenues were $42.0 million, an increase of 31% from the third quarter of 2009.

3 Nov 2010

PCIS releases ClaimsVISION SaaS delivered claims administration system

PCIS, a proven and trusted provider of policy administration and claims solutions, today announced the release and immediate availability of ClaimsVISION, a highly automated and user configurable, Software as a Service (SaaS) delivered claims administration system.

2 Nov 2010

RegeneRx announces positive results from RGN-259 non-clinical study for Dry Eye Syndrome

RegeneRx Biopharmaceuticals, Inc. today announced the results of its first non-clinical dry eye study using RGN-259, RegeneRx's ophthalmic, preservative-free eye drop for the treatment of Dry Eye Syndrome (DES). In the study, animals were treated with RGN-259, a vehicle control and a positive control, doxycycline.

2 Nov 2010

Eye Health News and Research

Latest Eye Health News and Research

Children with JIA face increase risk of developing cancer

DHA protects brain tissue and promotes recovery in acute ischemic stroke

TransTech Pharma, High Point receive $1.96 million grants under QTDP program

Angioblast Systems receives $1.2 million in grants under QTDP program

Researchers identify gene linked to melanoma metastasis

'Phantom' images brain keeps for visual comparisons stored in brain's neural network

FIP Annual Meeting to improve global health through advances in pharmaceutical sciences

pSivida awarded $489,000 grant under IRS Qualifying Therapeutic Discovery Project

Republicans look to use majority for health overhaul repeal, plan vote

Acton submits Manufacturing Supplement to FDA for AEROSPAN Inhalation Aerosol

Eye implant restores some vision in retinitis pigmentosa

QLT third quarter sales decreases 12.9% to $20.5 million

Northumbria University to host workshop on space exercise countermeasures and post mission rehabilitation

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

Retina Implant's microchip restores useful vision in patients blind due to retinitis pigmentosa

OMJPI enters agreement with Watson to distribute generic version of CONCERTA tablets

STAAR Surgical third quarter total net sales increases 6% to $13.2 million

ISTA third quarter net revenue increases 31% to $42.0 million

PCIS releases ClaimsVISION SaaS delivered claims administration system

RegeneRx announces positive results from RGN-259 non-clinical study for Dry Eye Syndrome

Genetics & Genomics - Second Edition eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in